October 11, 2024 – QuidelOrtho Company broadcasts the appointment of Jonathan Siegrist, PhD, as its new Government Vice President of Analysis and Growth (R&D) and Chief Expertise Officer (CTO), efficient October 7, 2024.

Siegrist brings a wealth of business experience and management expertise with greater than 15 years in molecular diagnostics, microfluidic platforms and biomedical engineering. He most lately served as CTO and Head of Assay Analysis and Growth at Cepheid. Earlier than Cepheid, he co-founded a diagnostic manufacturing firm.

Reporting to Brian Blaser, President and Chief Government Officer, Siegrist will lead QuidelOrtho's R&D technique, with a give attention to menu enlargement and advancing key platforms. His management is predicted to advance QuidelOrtho's main experience in immunoassay and molecular testing and award-winning options in scientific laboratories and transfusion medication. Werner Kroll, Senior Vice President R&D, will help a easy management transition and associated actions till his retirement in March 2025.

Proceed studying